Alpha-1 antitrypsin deficiency is a genetic cause of early-onset COPD that affects 1 in 2,000-5,000 people. Often missed, it can be managed with augmentation therapy and lifestyle changes. Testing is critical for those with unexplained lung or liver disease.
READ
